Viksna Anda, Sadovska Darja, Riekstina Vija, Nodieva Anda, Pole Ilva, Ranka Renate, Ozere Iveta
Rīga Stradiņš University, Riga, Latvia.
Riga East Clinical University Hospital, Centre of Tuberculosis and Lung Diseases, Ropaži Municipality, Upeslejas, Latvia.
J Clin Tuberc Other Mycobact Dis. 2024 Oct 31;37:100493. doi: 10.1016/j.jctube.2024.100493. eCollection 2024 Dec.
The recurrence of tuberculosis (TB) continues to place a significant burden on patients and TB programs worldwide. Repeated TB episodes can develop either due to endogenous reactivation of previously treated TB or exogenous reinfection with a distinct strain of (Mtb). Determining the precise cause of the recurrent TB episodes and identifying reasons for endogenous reactivation of previously successfully treated patients is crucial for introducing effective TB control measures.
Here, we aimed to provide a retrospective individual analysis of the clinical data of pulmonary TB patients with assumed endogenous infection reactivation based on WGS results to identify the reasons for reactivation. Patient medical files were reviewed to describe the provoking factors for endogenous reactivation.
In total, 25 patients with assumed endogenous TB reactivation were included in the study group, and 30 patients with one TB episode during the study period were included in the control group. There were no statistically significant differences identified between studied patient groups in patients age (t = -1.53, p = 0.13), body mass index (t = 0.82, p = 0.42), area of residency (χ = 0.015, p = 0.9), employment status (χ 0.076, p = 0.78) and presence of comorbidities (χ = 3.67, p = 0.78). Study group patients had statistically significantly more frequently positive sputum smear microscopy results (χ = 8.72, p = 0.0031), longer time to sputum smear (t = -2.2, p = 0.036) and sputum culture conversion (W = 198.5, p = 0.0029). Smoking was statistically significantly (χ = 5.77, p = 0.016) more frequently represented among study group patients. The median treatment duration for drug susceptible TB was 6 months in both in the control group (IQR 6-6) and among study group patients (IQR 6-7.75). The median treatment duration for multidrug-resistant TB was 20 months (IQR 17-23) in the control group and 19 months (IQR 16-19) in the study group patients.
Positive SSM for acid-fast bacteria, delayed time to sputum smear and sputum culture conversion, smoking, and incomplete therapy in the study group patients with multidrug-resistant TB should be considered as potential reasons for reactivation in recurrent TB patient group in our study.
结核病(TB)的复发继续给全球患者和结核病防治项目带来沉重负担。结核病反复发病可能是由于先前治疗过的结核病内源性再激活,也可能是由于再次感染了不同的结核分枝杆菌(Mtb)菌株。确定结核病反复发病的确切原因,并找出先前成功治疗的患者内源性再激活的原因,对于采取有效的结核病控制措施至关重要。
在此,我们旨在基于全基因组测序(WGS)结果,对假定为内源性感染再激活的肺结核患者的临床数据进行回顾性个体分析,以确定再激活的原因。查阅患者病历,描述内源性再激活的诱发因素。
研究组共纳入25例假定为内源性结核病再激活的患者,对照组纳入30例在研究期间有过一次结核病发作的患者。在研究的患者组之间,患者年龄(t = -1.53,p = 0.13)、体重指数(t = 0.82,p = 0.42)、居住地区(χ² = 0.015,p = 0.9)、就业状况(χ² = 0.076,p = 0.78)和合并症的存在情况(χ² = 3.67,p = 0.78)方面,未发现统计学上的显著差异。研究组患者痰涂片显微镜检查结果呈阳性的频率在统计学上显著更高(χ² = 8.72,p = 0.0031),痰涂片转阴时间更长(t = -2.2,p = 0.036),痰培养转阴时间也更长(W = 198.5,p = 0.0029)。研究组患者中吸烟的比例在统计学上显著更高(χ² = 5.77,p = 0.016)。对照组和研究组中对药物敏感结核病的中位治疗持续时间均为6个月(四分位间距IQR:6 - 6)。对照组中耐多药结核病的中位治疗持续时间为20个月(IQR:17 - 23),研究组患者为19个月(IQR:16 - 19)。
在我们的研究中,研究组耐多药结核病患者中抗酸杆菌痰涂片阳性、痰涂片和痰培养转阴时间延迟、吸烟以及治疗不完整,应被视为复发性结核病患者组再激活的潜在原因。